CClinicalTrials.gg
RecruitingNCT07499648Updated Apr 28, 2026

Baby Steps to Care

An interventional study of Care Box in Prenatal Follow Up Care, sponsored by University Hospitals Cleveland Medical Center. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by University Hospitals Cleveland Medical Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The purpose of this research study is to understand if receipt of extra prenatal resources from the ED visit improves i) the patient's ability to engage in prenatal services after the ED visit, and ii) how it impacts the patient's pregnancy knowledge and confidence. If participant's consent to this study, the participants will receive standard of care and additionally be randomized, like flipping a coin, to receive either i) extra prenatal care resources in the form of a 'care box' during this ED visit, or ii) the extra prenatal care resources in the form of a 'care box" two weeks from today. All participants will also receive a follow-up survey asking about the patient's engagement in prenatal services following ED visit, perceptions of pregnancy knowledge and confidence, the usefulness of the resources received, and what additional resources might have been helpful during the early stages of pregnancy. Participation in this study will not require any additional clinic or hospital visits. The total time involved is approximately 20 minutes during the initial ED visit and less than 20 minutes to complete the follow-up survey. Investigators hope to enroll a total of 50 participants in this study.

02

Conditions studied

  • Prenatal Follow Up Care

Keywords

  • Emergency Department Visit
03

In context

Lead sponsor

University Hospitals Cleveland Medical Center is the lead sponsor of 283 studies on the registry; 42 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 29 (91%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Found to be pregnant in the CMC Emergency Department through serum or urine pregnancy testing (hcg) or point of care (POC) urine testing
  • Ability to provide verbal consent to this study

Exclusion criteria

Exclusion Criteria:

  • Prisoners
  • Non-Ohio residents
  • Serious medical conditions (severe cardiovascular disease, infections, trauma) or critical illness requiring urgent hospitalization
  • Nonpregnant persons including men
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Care Box - Now

    Providing care box during the ED visit

    Behavioral: Care Box

  • Active comparator
    Care Box - Future

    Will be provided care box at a future date

    Behavioral: Care Box

Interventions

  • BehavioralCare Box

    The resources in the care box include a water bottle, pocket calendar (monthly planner) and pen, recorder in the shape of a heart, bus pass, mini stuffed animal, and a welcome insert (includes descriptions for the items and a QR code with additional resources) additionally, the QR code will be on the inside of the box's top as well as on the insert.

06

What researchers measure

Primary outcomes

  1. Change in number of OBGYN follow up appointments as measured by medical record review

    Time frame: 1 week, 1 month, 3 months, 6 months, 9 months

Secondary outcomes

  1. Number of participants with a pregnancy outcome of 1 as measured by medical record review

    Pregnancy outcome of 1 is defined as full term live birth with healthy weight (\> 2500g)

    Time frame: Up to 9 months

  2. Number of participants with a pregnancy outcome of 2 as measured by medical record review

    Pregnancy outcome of 2 is defined as full term live birth with low birth weight (\< 2500g)

    Time frame: Up to 9 months

  3. Number of participants with a pregnancy outcome of 3 as measured by medical record review

    Pregnancy outcome of 3 is defined as pre-term live birth (\< 37 weeks)

    Time frame: Up to 9 months

  4. Number of participants with a pregnancy outcome of 4 as measured by medical record review

    Pregnancy outcome of 4 is defined as miscarriage/spontaneous abortion

    Time frame: Up to 9 months

  5. Number of participants with a pregnancy outcome of 5 as measured by medical record review

    Pregnancy outcome of 5 is defined as stillbirth (fetal death at/after 28 weeks)

    Time frame: Up to 9 months

  6. Number of participants who affirmed the care box supported the pregnancy as measured by patient survey

    Time frame: Up to 1 week

07

Study locations

1 of 1 sites recruiting
  • University University Cleveland Medical Center
    Cleveland, Ohio 44106, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07499648
Lead sponsor
University Hospitals Cleveland Medical Center
Responsible party
Kiran Faryar, MD (Department of Emergency Medicine Vice Chair of Research, University Hospitals Cleveland Medical Center) — Principal investigator
First posted
Mar 30, 2026
Start date
Apr 23, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Apr 28, 2026

Study contacts

Andie Moore, MS
Contact
andie.moore@uhhospitals.org
(216) 286 - 7239
Kiran Faryar, MD, MPH
principal investigator · University Hospitals Cleveland Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion